Daniel M. Weingrow

Daniel Weingrow practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Daniel Weingrow's NPI, 1013113679, was assigned on June 21, 2007. Daniel Weingrow graduated from WesternU College of Osteopathic Medicine of the Pacific in 2007. Daniel Weingrow holds California license 20A10747.

Daniel Weingrow's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Daniel Weingrow's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. The medical group on file is Vituity. Dmand AI also links Daniel Weingrow to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Daniel Weingrow practices. Vendor and product names are available with a free account.

Emergency medicine is Daniel Weingrow's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Daniel Weingrow is board certified in emergency medicine by the AOA Board of Emergency Medicine. Dmand AI has Daniel Weingrow's licenses on file in 2 states: California and Pennsylvania.

CMS data shows 458 Medicare services from Daniel Weingrow across 5 procedure codes in 2024, for 415 Medicare patients. Medicare paid $59,680 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 415 Medicare patients who saw Daniel Weingrow in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 2.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Daniel Weingrow's median patient age at 43, with 46% women.

In 2024, Daniel Weingrow wrote 66 Medicare Part D claims for 51 patients. 92% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $50 in total drug cost. In 2019, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Daniel Weingrow for performance year 2024, reported as part of a group.

Dmand AI links 1 paper to Daniel Weingrow in 2018. Daniel Weingrow's most frequent co-author is Jacob Francis Lentz, MD.

Daniel Weingrow graduated from WesternU College of Osteopathic Medicine of the Pacific in 2007. Daniel Weingrow is a member of ACEP and AOA.

Daniel Weingrow is in network with 4 carriers, including United Healthcare, CMS Medicare and NV State Medicaid. Medicaid plans come from the most carriers, 2. Check the plan with the practice before a visit.